Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer Read more about Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer
A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers Read more about A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers
A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer Read more about A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer
Study of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC) Read more about Study of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC)
An Open Label, Randomized Study of Neoadjuvant Nivolumab and Chemotherapy, With or Without Sub-ablative Stereotactic Body Radiation Therapy, for Resectable Stage IIA to IIIB Non-small Cell Lung Cancer Read more about An Open Label, Randomized Study of Neoadjuvant Nivolumab and Chemotherapy, With or Without Sub-ablative Stereotactic Body Radiation Therapy, for Resectable Stage IIA to IIIB Non-small Cell Lung Cancer
Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated With Chemoradiation Therapy Read more about Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated With Chemoradiation Therapy
XB2001 in Combination With ONIVYDE + 5-FU/LV (+Folinic Acid) in Advanced Pancreatic Cancer Read more about XB2001 in Combination With ONIVYDE + 5-FU/LV (+Folinic Acid) in Advanced Pancreatic Cancer
A Study of FWD1509 in Adults With Non-Small Cell Lung Cancer Read more about A Study of FWD1509 in Adults With Non-Small Cell Lung Cancer
Financial Distress During Treatment for Pediatric Acute Lymphoblastic Leukemia in the United States Read more about Financial Distress During Treatment for Pediatric Acute Lymphoblastic Leukemia in the United States
Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain Amyloidosis Read more about Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain Amyloidosis